← Chemical Peel

Chemical Peel for Sensitive Skin

Written & medically reviewed by the Dermapedia team
At a Glance

A light peel can be done on sensitive skin, but the honest answer for some people is not to peel at all. If your skin is currently inflamed, broken, flaring with eczema, or in the middle of a rosacea flush, a peel is the wrong move that week. If it is calm but simply stings easily, a superficial peel with a gentle agent, a low concentration and a single coat is a reasonable thing to try, in that order and with a patch test first.

There is no trial of chemical peels in rosacea, and none in eczema. That is not a gap in this page, it is a gap in the literature. No randomized or prospective trial of peeling rosacea has been published, and the only eczema-adjacent record is a single case report in a different barrier disorder. Everything you will be told about peeling reactive skin is convention and first principles, and you deserve to know that before you decide.

No chemical peel product has FDA approval, which matters most to this reader. FDA stated on 30 July 2024 that "the agency has not approved any chemical peel products, and consumers should only consider using chemical peel products under the supervision of a dermatologist or licensed and trained practitioner." The same warning named products sold direct to consumers at trichloroacetic acid 50 to 100 percent, lactic acid 90 percent, salicylic acid 80 percent and glycolic acid 70 percent. If your skin reacts to everything, buying a strong peel online is the single worst version of this decision.

The strength and the number of coats matter more than which acid is on the label. Depth is not a property of the bottle. It is a function of the agent, its concentration, its pH, how many coats go on, how the skin was degreased first, how thick your skin is, and how hard the clinician presses. The same 35% TCA can land as a light peel or a medium one. This is why "what acid is it" is the second question and "how strong, how many coats, and how deep are you aiming" is the first.

The gentler agents are gentler on tolerability evidence, not on efficacy evidence. Mandelic acid, salicylic-mandelic combinations and buffered glycolic acid all have trials showing equal results with fewer side effects than their comparators. Those trials were run in people with acne and melasma who had normal skin barriers, not in people with rosacea or eczema, so the tolerability finding transfers as an educated guess rather than as proof.

Key Facts

FDA approval statusNo chemical peel product has FDA approval, per FDA's statement of 30 July 2024
FDA clearance statusNo 510(k) clearance exists for any chemical peel
Trials of peels in rosacea or in eczemaNone published
Total published studies of peels in skin of color7, from 473 screened in a scoping review
Gentlest agents with tolerability evidenceMandelic acid, salicylic-mandelic combination, buffered glycolic acid at pH 3.0
Salicylic acid in Fitzpatrick V and VI20% and 30%, five peels, n=25; 88% moderate-to-significant improvement, side effects in 16%
Salicylic-mandelic vs glycolic acidn=90 randomized; equal efficacy (60.98% vs 62.36% melasma score reduction, p=0.876), salicylic-mandelic better tolerated
Buffered glycolic vs Jessner'sn=20 split-face; no significant difference in effect, fewer side effects on the buffered glycolic side
Depth by skin toneSuperficial peels widely used in Fitzpatrick IV-VI; medium peels "require caution"; deep peels "should be avoided altogether"
Priming2 to 4 weeks of a lightening cream, with or without a retinoid, features in nearly every successful protocol in deeply pigmented skin
Isotretinoin2017 consensus found insufficient evidence to delay superficial peels; medium and deep peels are not covered by that finding
Expected redness3 to 5 days after a superficial peel; 15 to 30 days after a medium peel

What "sensitive skin" actually covers

The phrase is used for at least four different things, and they do not carry the same risk.

Skin that simply stings. No visible redness, no diagnosis, but acids, alcohol, fragrance and sometimes water sting on contact. This is the most peelable version of sensitive skin. It usually reflects a low irritation threshold rather than active disease, and a low-concentration superficial peel with a single coat is a reasonable trial.

A damaged barrier. Skin that is flaking, tight, shiny in patches, and reacting to products that used to be fine, usually after over-exfoliating, a strong retinoid, or a course of something drying. This is temporary and it is fixable, and the sensible move is to repair it first. A peel on a stripped barrier goes deeper than the same peel on intact skin, because the outer layer that would normally slow the acid down is not there.

Rosacea. Flushing, persistent redness across the central face, visible small vessels, sometimes bumps and pustules. Rosacea skin is reactive by definition, and there is no trial evidence at all about peeling it. Peels are used in rosacea in practice by some clinicians, cautiously, at low strength. That is practice, not evidence.

Eczema, or atopic dermatitis. An inflammatory disease with a genuinely defective barrier. There is no trial of peeling eczema either. Active eczema is the clearest case for waiting: the barrier is not intact, the skin is already inflamed, and a controlled chemical injury on top of an uncontrolled one is not controlled anymore.

Two more situations belong in this list even though people do not always call them sensitivity. Deeply pigmented skin is not more fragile, but it is more likely to respond to any inflammation with dark patches afterward, which changes the calculation about depth. And skin that has just had something else done to it — waxing, threading, a laser, a strong retinoid, a course of another peel — is temporarily sensitive whatever it is like normally.

Which agents are gentler, and what that is actually based on

The gentleness ranking that circulates online is roughly right and its evidence is thinner than it sounds. Here is what has actually been measured.

Mandelic acid. A larger molecule than glycolic acid, so it penetrates more slowly and more evenly. In a randomized trial of 50 people with mild to moderate acne, 45% mandelic acid and 30% salicylic acid over six sessions produced no significant overall difference in acne score, with salicylic acid better for blackheads and whiteheads, mandelic better for inflamed spots, and fewer adverse effects with mandelic. That is a genuine tolerability result at equal efficacy.

Salicylic-mandelic combinations. In a three-arm randomized trial of 90 people with melasma, a 20% salicylic and 10% mandelic combination reduced the melasma score by 60.98 percent against 62.36 percent for 35% glycolic acid, a difference that was not statistically significant. The authors' conclusion was that salicylic-mandelic peels are better tolerated and more suitable for Indian skin. In pooled acne evidence, the salicylic-mandelic combination came out ahead of glycolic acid, at 85.3 percent versus 68.5 percent improvement in total acne score.

Salicylic acid at superficial strengths. The foundational study for "salicylic acid is the safe one in deeply pigmented skin" is a 25-person series in Fitzpatrick types V and VI, using 20% and 30% at two-week intervals after two weeks of priming: 88 percent had moderate to significant improvement and 16 percent had minimal to mild side effects. Twenty-five people. Worth knowing, not worth treating as settled. A separate study of 24 people using 30% salicylic acid measured skin color instrumentally and found a lightening effect rather than darkening.

Buffered glycolic acid. The reason this matters is that plain glycolic acid sits at a very low pH, and pH is a large part of why it stings and why it works. In a split-face randomized trial of 20 people with acne, a buffered 50% glycolic acid at pH 3.0 with 0.5% salicylic acid was compared with Jessner's solution. There was no significant difference in lesion count, acne severity or subjective effect, and the buffered glycolic side had fewer side effects. Same result, gentler delivery, which is the cleanest published demonstration that how an acid is formulated matters as much as how much of it there is.

One correction to a popular claim. Mandelic acid is often described as the best acid for pigment as well as the gentlest. On efficacy it has lost head-to-heads: in a comparison of 30% mandelic against 30% lactic acid for dark circles, lactic acid did better, with 50 percent of the lactic group achieving more than 30 percent improvement and higher satisfaction. Gentle and best are not the same axis.

And the caveat that applies to all of it. Every one of these trials was run in people with acne or melasma and otherwise normal skin barriers, mostly in South Asian populations, with 20 to 90 participants each. None was run in rosacea or eczema. The tolerability findings are real, and applying them to reactive skin is an extrapolation.

Why the concentration and the number of coats matter more than the acid's name

This is the single most useful thing to understand before you sit in the chair.

Peels are classified by the depth they reach, not by what is in them. A superficial peel causes a localized injury inside the epidermis, the outer compartment of the skin. A medium peel goes through the epidermis into the papillary dermis just below. A deep peel reaches the mid-reticular dermis. Risk rises steeply with each step, and for sensitive skin, so does the chance of a long red aftermath.

Depth is judged during the appointment by how white the skin turns, not by what was in the bottle. Stringy or patchy light frosting is the superficial endpoint. A uniform white coating with a little redness showing through is the medium endpoint. A solid white enamel look is the deep endpoint. A clinician watching for frost is controlling depth in real time.

That is why "a 35% TCA peel" is not a fixed strength. The same solution reaches different depths depending on how many coats are applied, how thoroughly the skin was degreased first, how thick the skin is in that area, and how hard the applicator is pressed. Published sources do not even agree on where 35% TCA sits: one standard reference calls it medium, another calls medium 35 to 50 percent. Both agree that above 50 percent is deep.

Two practical consequences for reactive skin. First, one coat of a light agent is a genuinely different procedure from three coats of the same agent, and asking how many coats are planned is a fair question. Second, published micron depths for peels are widely repeated but have no primary source behind them, so anyone quoting a precise depth in millimeters is quoting a textbook figure that cannot be traced.

There is also something you may not be able to find out. Professional-use-only products are legally exempt from the requirement to carry a consumer ingredient list. That is why several well-known branded peels publish their ingredients but not their concentrations, and it is why an independent depth classification of those products is not possible from public information. If a clinic tells you a branded peel is medium-depth, that is the marketing description, not a verified fact.

Patch testing, priming and the sensible order of operations

Patch test first if your skin reacts to things. Apply the same product, at the same strength, to a small discreet area — behind the ear or along the jawline is usual — and wait. This is standard practice rather than a trial-tested protocol, and it will not predict everything, but it will catch a frank allergic or severe irritant reaction before it happens across your whole face. It is particularly worth doing where the peel contains an ingredient people react to. Some professional peels contain phenol, hydroquinone, resorcinol or salicylates, and allergy to aspirin is a genuine contraindication to salicylic acid.

Repair the barrier before you peel it. If your skin is currently flaking, stinging in the shower or reacting to a moisturizer, that is not the week. A bland routine, no acids, no retinoid, no scrubs, and a plain moisturizer for two to four weeks changes what the peel will do, because an intact outer layer is what slows the acid down.

Priming is a real thing and it is in nearly every successful protocol. In the studies that produced good results in deeply pigmented skin, patients were prepared for two to four weeks beforehand with a lightening cream, often with a retinoid alongside. Priming is standard practice in those protocols rather than a separately tested intervention, but the pattern is consistent enough to be worth asking about.

Start light and go up, never the reverse. Depth can always be added at the next session. It cannot be taken back.

Stop the actives before and after. Retinoids, exfoliating acids, scrubs and anything described as brightening will all sensitize skin. Your provider should tell you when to stop them; if they do not, ask.

And treat sun protection as part of the procedure, not an afterthought. FDA documented that after four weeks of using alpha hydroxy acids, volunteers showed an 18 percent increase in sensitivity to skin reddening from UV and roughly double the sensitivity to UV-induced cellular damage, and that this reverses after stopping. FDA's own recommended wording for AHA products advises sun protection during use and for a week afterwards. That is the best-sourced aftercare instruction in this entire subject.

When the right answer is not to peel

Peels are useful, popular and often reasonable. They are also not the only option, and for some skin the correct advice is to do something else.

Do not peel skin that is actively inflamed or broken. Active infection, open wounds and active eczema or rosacea flares are standard contraindications, and they are not judgment calls. A peel is a controlled injury, and control requires starting from intact skin.

Do not peel deeply if your skin is deeply pigmented. Published guidance is graded by depth: superficial peels are frequently used in Fitzpatrick types IV to VI and give good satisfaction, medium peels require caution, and deep peels should be avoided altogether. The reason is dark patches afterward, which is the commonest complication of TCA peeling. Real numbers exist and they are modest, not alarming: 12.5 percent temporary hyperpigmentation with no scarring in a series of 40 mostly type V patients on a strong sequential protocol, and 28 percent at four weeks after a single 15% TCA peel in 18 Korean women, resolved in all but one by 12 weeks.

Be aware how thin the evidence is for peeling skin of color at all. A scoping review screened 473 studies and found 7 that met inclusion criteria. Five were about acne or acne scarring and reported positive results with minimal adverse effects. One reported chemical burns from improper use. Seven studies is the entire base.

And know that a peel may not beat what you would be prescribed anyway. In acne scarring in Fitzpatrick types IV to VI, a randomized trial of 60 people found microneedling produced improvement in 73 percent against 33 percent for a 35% glycolic peel. In a review of the retinoic acid peel, the authors concluded that a properly designed comparison against simply prescribing tretinoin cream has still not been done. If your skin is reactive, an approach that does not involve a chemical injury at all is a legitimate answer rather than a consolation prize.

Before you book

If you get cold sores, say so when you book, not on the day of the appointment. Antiviral medicine is started in advance, because reactivation happens while the skin is healing and the drug needs to already be working. In a series of 181 patients having perioral phenol peels or dermabrasion, those with a history of cold sores who got no antiviral had an outbreak half the time; with standard antiviral cover that fell to 8.3 percent, and after a higher-dose regimen was introduced no further outbreaks were seen. Notably, 6.6 percent of patients with no history of cold sores at all had an outbreak too. Reactivation has been reported after a superficial peel, so a light peel is not exempt. Published protocols start the antiviral either two days before, the day before, or at the latest on the day. None start afterward.

If you take or recently took isotretinoin, say so, and expect a more specific answer than the old rule. The historic instruction to wait six months came from the drug's package insert and three small case series from the mid-1980s. A 2017 systematic review and consensus covering 32 publications and 1,485 procedures found insufficient evidence to justify delaying superficial chemical peels, manual dermabrasion, cutaneous surgery, laser hair removal, and fractional ablative and non-ablative lasers. A separate 2017 task force reached the same conclusion for superficial peels and non-ablative lasers, and added that superficial and focal dermabrasion may be safe when done by a well-trained clinician. Both stop short of medium and deep peels, which are not covered by the "insufficient evidence to delay" finding. A third consensus from India goes further and includes medium-depth peels and microdermabrasion. The consensus is also not universally accepted and has drawn published criticism. What that adds up to: a superficial peel while on or recently off isotretinoin is supported by current consensus, a medium or deep peel is not.

Tell your provider about aspirin or salicylate allergy, about allergy to phenol, hydroquinone or resorcinol, about any autoimmune or liver condition, about a tendency to form thick raised scars, and about any current skin infection. Ask what the acid is, at what concentration, at what pH, and how many coats are planned. Ask what they would do if your skin frosts faster than expected.

Ask who is performing it and what they are licensed to do. In the states that have written it down, the legal test is depth. Ohio, Texas and California all limit estheticians to exfoliation of the epidermis, and medium and deep peels are treated as medical procedures. Ohio adds a numeric safe harbour — 30 percent concentration and a pH of at least 3, with stronger products allowed only where the manufacturer documents that they do not penetrate below the stratum corneum. There is no federal rule and no reliable nationwide table, so check your own state board.

Do not buy a peel online to do yourself. This is the situation FDA's 2024 warning was written about, and its description of the harms is worth reading in its own words: these products "remove layers of skin to varying depths and may cause severe chemical burns, pain, swelling, infection, skin color changes, and disfiguring scars. These injuries may even require emergency care or specialty care from a dermatologist or surgeon."

Get emergency help now

  • Fever or chills in the days after a peel
  • Redness spreading outward from the treated area instead of fading, or pus
  • Pain that is rapidly increasing rather than settling
  • Skin that has turned grey or white and does not blanch, or skin that has blistered or come away outside the pattern that was treated, which can mean a burn deeper than intended
  • During or after a deep phenol peel: chest pain, palpitations, an irregular or racing heartbeat, fainting, or feeling very unwell

Call your provider if

  • Redness lasts beyond about 5 days after a superficial peel, or beyond about a month after a medium peel
  • Blistering, crusting or an open weeping area appears
  • An area of skin gets noticeably darker, or noticeably lighter, over the following weeks
  • A cluster of small painful blisters appears, which can be a cold sore flare
  • Small firm white bumps appear in the treated skin
  • Itching, swelling or a rash spreads beyond the treated area, which can mean a reaction to something in the solution or the aftercare products
  • Anything is getting worse after day three instead of better
Questions people ask+
Can I have a chemical peel if I have rosacea?There is no trial evidence either way. No randomized or prospective study of chemical peeling in rosacea has been published, so nobody can tell you a risk figure or a success rate. In practice, some clinicians use very light peels on rosacea skin between flares, cautiously and at low strength, and defer entirely during a flare. That is a clinical judgment, not a published recommendation, and it should be presented to you as one.
What is the gentlest chemical peel?On the evidence, mandelic acid, a salicylic-mandelic combination, and buffered glycolic acid at pH 3.0 are the three with trials showing equal results and fewer side effects than their comparators. But gentleness is not only about the acid. A single coat of a low concentration at a higher pH on well-prepared skin is gentler than the same acid at higher strength in three coats, whatever the label says.
Should I patch test a peel?Yes, if your skin reacts to things. The same product at the same strength on a small discreet area, behind the ear or along the jawline, will catch a frank allergic or severe irritant reaction before it happens across your face. It is standard practice rather than a tested protocol, and it will not predict every reaction. It is especially worth doing if you have aspirin or salicylate allergy, or a history of reacting to phenol, hydroquinone or resorcinol.
Is any chemical peel FDA approved?No. FDA stated on 30 July 2024 that it "has not approved any chemical peel products, and consumers should only consider using chemical peel products under the supervision of a dermatologist or licensed and trained practitioner." There is also no 510(k) clearance for any peel. That does not make peels illegal or unregulated; it means no US authority reviews a peel formula before it is sold, and FDA acts afterward against sellers whose marketing claims turn the product into an unapproved drug.
Can I do a peel on eczema?Not on active eczema. There is no trial of peeling eczema or atopic dermatitis at all; the only related published record is a single case report in a different barrier disorder. The reason to wait is mechanical rather than theoretical: eczema skin has a defective barrier, so an acid penetrates further than intended, and adding a controlled injury to an uncontrolled one removes the control. Once the skin is clear and calm, a light peel becomes a conversation worth having.
Will a peel make my skin more sensitive afterward?Temporarily, yes, and specifically to sun. FDA documented an 18 percent increase in sensitivity to UV reddening and roughly double the sensitivity to UV-induced cellular damage after four weeks of alpha hydroxy acid use, and noted that the increase is reversible after stopping. FDA's recommended label wording advises sun protection during use and for a week afterwards. Daily sunscreen after a peel is the best-sourced instruction in this entire subject.
Is a stronger peel a better peel?No, and the concentration on the label is a poor guide to anything. Depth depends on the agent, the concentration, the pH, the number of coats, how the skin was degreased, how thick the skin is and how hard the applicator is pressed, and the clinician judges it during the appointment by how white the skin turns. In pooled evidence from 12 randomized acne trials, most peels performed about the same as each other, and the reviewers described the underlying trial quality as very low to moderate.
Which peel is safest for darker skin?Superficial ones, and specifically salicylic acid, mandelic acid and salicylic-mandelic combinations, with buffered or primed glycolic acid also well supported. Published guidance grades it by depth: superficial peels are frequently used in Fitzpatrick types IV to VI with good satisfaction, medium peels require caution, and deep peels should be avoided altogether. Note the size of the base, though: a scoping review screened 473 studies and found 7 that qualified.
References+
US Food and Drug Administration. FDA warns against purchasing or using chemical peel skin products without professional supervision. FDA Drug Alerts and Statements, 30 July 2024. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-against-purchasing-or-using-chemical-peel-skin-products-without-professional-supervision
Source of the verbatim statement that no chemical peel product is FDA approved, of the list of concentrations sold direct to consumers, and of FDA's description of the harms.
Soleymani T, Lanoue J, Rahman Z. A Practical Approach to Chemical Peels. J Clin Aesthet Dermatol. 2018;11(8):21-28. https://pubmed.ncbi.nlm.nih.gov/30214663/
Source for the depth classification, the frosting endpoints used to judge depth during the procedure, and the agent-by-concentration table.
Samargandy S, Raggio BS. Chemical Peels for Skin Resurfacing. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK547752/
Second reference for the depth bands, the contraindication list, healing times, and the caution about Fitzpatrick types III to VI.
Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18-22. https://pubmed.ncbi.nlm.nih.gov/9935087/
The 25-person series in Fitzpatrick types V and VI: 88% moderate-to-significant improvement, minimal-to-mild side effects in 16%.
Sarkar R, Garg V, Bansal S, Sethi S, Gupta C. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma. Dermatol Surg. 2016;42(3):384-391. https://pubmed.ncbi.nlm.nih.gov/26859648/
The three-arm randomized trial of 90 patients: glycolic 62.36% versus salicylic-mandelic 60.98% melasma score reduction, not significantly different, with salicylic-mandelic better tolerated.
Comparative study of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris. J Cosmet Dermatol. 2020;19(2):393-399. https://pubmed.ncbi.nlm.nih.gov/31553119/
The 50-person randomized trial showing equal overall acne efficacy with fewer adverse effects for mandelic acid.
Comparison of a buffered 50% glycolic acid with 0.5% salicylic acid versus Jessner's solution in acne vulgaris. J Cosmet Dermatol. 2018;17(5):797-801. https://pubmed.ncbi.nlm.nih.gov/29164826/
The split-face trial in 20 people showing no difference in effect with fewer side effects on the buffered, higher-pH side.
Noninvasive Cosmetic Treatments for Fitzpatrick IV-VI: A Narrative Review of Safety and Efficacy Guidelines. Plast Reconstr Surg Glob Open. 2026;14(3):e7541. https://pubmed.ncbi.nlm.nih.gov/41884758/
Source for the depth-graded position in darker skin: superficial peels frequently used, medium peels require caution, deep peels should be avoided altogether.
Chemical peels in skin of color: a scoping review. Cureus. 2026. https://pubmed.ncbi.nlm.nih.gov/42306365/
The size of the evidence base: 473 studies screened, 7 met inclusion criteria, one documenting chemical burns from improper use.
Maruma F, Dlova N, Mofokeng TRP, Ngwenya E. The effects and safety of sequential high concentration glycolic acid and trichloroacetic acid chemical peels in skin photo-type IV-VI, a retrospective cross-sectional monocentric review. Int J Womens Dermatol. 2025;11(3):e209. https://pubmed.ncbi.nlm.nih.gov/40620441/
Retrospective series of 40 patients, 77.5% Fitzpatrick V: irritation 77.5%, post-peel cracking 62.5%, transient hyperpigmentation 12.5%, no scarring.
Split-face comparison of 1550 nm fractional photothermolysis versus 15% trichloroacetic acid peel in melasma. J Cosmet Laser Ther. 2012;14(2):81-86. https://pubmed.ncbi.nlm.nih.gov/22372386/
Source for post-inflammatory hyperpigmentation in 28% of 18 Korean women at 4 weeks, resolving in all but one by 12 weeks.
Chemical peels for acne vulgaris: a systematic review of randomized controlled trials. BMJ Open. 2018;8(4):e019607. https://pubmed.ncbi.nlm.nih.gov/29705755/
The pooled evidence across 12 randomized trials and 387 participants showing most peels perform similarly, with the authors' own statement that trial quality was very low to moderate.
alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol. 2000;1(2):81-88. https://pubmed.ncbi.nlm.nih.gov/11702315/
The only substantive published patient-management guidance retrieved for AHA procedures in reactive skin; dated, and cited here as guidance rather than as trial evidence.
A Case of Ichthyosis Vulgaris and the Use of 70% Glycolic Acid Chemical Peels for Management. Cureus. 2022;14(9). https://pubmed.ncbi.nlm.nih.gov/36159354/
The single case report that represents the nearest published record to peeling a barrier-defective skin condition; n=1.
Spring LK, Krakowski AC, Alam M, et al. Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations. JAMA Dermatol. 2017;153(8):802-809. https://pubmed.ncbi.nlm.nih.gov/28658462/
Systematic review of 32 publications and 1,485 procedures; insufficient evidence to delay superficial chemical peels, with the origin of the old six-month rule in three small case series from the mid-1980s.
Waldman A, Bolotin D, Arndt KA, et al. ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use. Dermatol Surg. 2017;43(10):1249-1262. https://pubmed.ncbi.nlm.nih.gov/28498204/
The task force finding for superficial peels and non-ablative lasers, and the note that superficial and focal dermabrasion may be safe with a well-trained clinician. Medium and deep peels are not covered.
Mysore V, Mahadevappa OH, Barua S, et al. Standard Guidelines of Care: Performing Procedures in Patients on or Recently Administered with Isotretinoin. J Cutan Aesthet Surg. 2017;10(4):186-194. https://pubmed.ncbi.nlm.nih.gov/29491653/
The broader consensus that also clears superficial and medium-depth peels and microdermabrasion, used here to show that the consensus documents do not fully agree.
Perkins SW, Sklarew EC. Prevention of facial herpetic infections after chemical peel and dermabrasion. Plast Reconstr Surg. 1996;98(3):427-433. https://pubmed.ncbi.nlm.nih.gov/8700976/
The cold sore figures: 50% outbreak with a history and no antiviral, 8.3% with standard prophylaxis, none after the higher-dose regimen, and 6.6% in patients with no history.
Johnson N. First-ever HSV-1 recurrence following superficial facial chemical peel after 30-year latency following neonatal primary infection. J Cosmet Dermatol. 2020;19(1):135-136. https://pubmed.ncbi.nlm.nih.gov/31050128/
The basis for saying superficial peels are not exempt from cold sore reactivation.
Comparative study of microneedling versus 35% glycolic acid peel in atrophic acne scars in Fitzpatrick types IV-VI. J Clin Aesthet Dermatol. 2022;15(6):48-52. https://pubmed.ncbi.nlm.nih.gov/35783564/
Randomized trial of 60 patients in which microneedling produced improvement in 73.33% versus 33.33% for the glycolic peel.
Sumita JM, Leonardi GR, Bagatin E. Tretinoin peel: a critical view. An Bras Dermatol. 2017;92(3):363-366. https://pubmed.ncbi.nlm.nih.gov/29186249/
Source for the point that a controlled comparison of a retinoic acid peel against simply prescribing tretinoin cream has not been properly done.
FDA. Alpha Hydroxy Acids. https://www.fda.gov/cosmetics/cosmetic-ingredients/alpha-hydroxy-acids
Source for the 18% increase in UV reddening sensitivity, the roughly doubled UV cellular damage sensitivity, the reversibility of both, the 10% and pH 3.5 consumer safety envelope, and the exemption of professional-only products from consumer ingredient labeling.
Ohio Administrative Code Rule 4713-8-04. https://codes.ohio.gov/ohio-administrative-code/rule-4713-8-04
The numeric state limit: estheticians capped at 30% concentration and pH not less than 3, with stronger products permitted only where the manufacturer documents that they do not penetrate below the stratum corneum.
Texas Department of Licensing and Regulation. Medspas at a Glance. https://www.tdlr.texas.gov/media/pdf/Medspas-at-a-Glance.pdf
The depth-based version of the same rule: light or superficial peels within esthetician scope, medium and deep peels classed as medical procedures.
← Back to Chemical Peel